Inspire Investing LLC Sells 446 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Inspire Investing LLC lessened its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 12.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,011 shares of the company’s stock after selling 446 shares during the quarter. Inspire Investing LLC’s holdings in Addus HomeCare were worth $350,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. Amalgamated Bank raised its stake in Addus HomeCare by 8.4% during the 2nd quarter. Amalgamated Bank now owns 5,330 shares of the company’s stock worth $619,000 after buying an additional 412 shares during the period. Dimensional Fund Advisors LP raised its stake in Addus HomeCare by 0.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after buying an additional 5,421 shares during the period. American Century Companies Inc. raised its stake in Addus HomeCare by 90.6% during the 2nd quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock worth $2,136,000 after buying an additional 8,743 shares during the period. Van Hulzen Asset Management LLC raised its stake in Addus HomeCare by 5.4% during the 2nd quarter. Van Hulzen Asset Management LLC now owns 30,175 shares of the company’s stock worth $3,504,000 after buying an additional 1,551 shares during the period. Finally, Texas Permanent School Fund Corp raised its stake in Addus HomeCare by 0.6% during the 2nd quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock worth $1,636,000 after buying an additional 82 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insider Buying and Selling

In related news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at $429,165. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 22,917 shares of company stock worth $3,050,082. Company insiders own 4.60% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on ADUS. Royal Bank of Canada reaffirmed an “outperform” rating and set a $141.00 price objective on shares of Addus HomeCare in a research note on Tuesday, September 3rd. TD Cowen lifted their price target on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Oppenheimer lifted their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday. Stephens reissued an “overweight” rating and issued a $138.00 price target on shares of Addus HomeCare in a research note on Tuesday, August 6th. Finally, Macquarie assumed coverage on Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 price target on the stock. One research analyst has rated the stock with a sell rating and eight have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $128.29.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $132.84 on Tuesday. The stock’s 50-day simple moving average is $127.32 and its 200 day simple moving average is $114.50. The company has a market cap of $2.40 billion, a P/E ratio of 32.96, a P/E/G ratio of 2.33 and a beta of 1.04. Addus HomeCare Co. has a 52-week low of $78.35 and a 52-week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14. The business had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. Addus HomeCare’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.94 earnings per share. As a group, equities analysts predict that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.